Oncology

Filter

Toripalimab JUPITER-02 and -06 data

4 Mins

April 2026

Updated clinical data from the Phase III JUPITER-02 and JUPITER-06 trials of the anti-PD1 antibody toripalimab in NPC and OSCC, presented…

CAR-T Cell Immunotherapy for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic modalities such as…

Aggressive Vulvar Angiomyxoma in Term Pregnancy

Aggressive angiomyxoma (AA) is a rare, slow-growing, but locally infiltrative mesenchymal tumour primarily affecting women of…

Evolving the Future of Breast Cancer Care: An Interview with Komal Jhaveri

Komal Jhaveri – Breast Medical Oncologist and Early Drug Development Specialist, Memorial Sloan Kettering Cancer Center, New York, USA…

Endometrial Cancer Treatment

According to USA data, around 15% of patients with endometrial cancer (EC) have advanced disease at diagnosis, which is…

10 Sep 2025

Avelumab 1L Maintenance in aUC: Insights from 5000+ Real-World Patients

Urothelial carcinoma (UC), a prevalent cancer affecting the urinary tract, often progresses to an advanced, terminal…

Retracted: Sponsored content: ADC-IO combination in comorbid patients with advanced urothelial cancer

This article has now been retracted and a retraction statement has been published.

Paradigm Changes in Prostate Cancer Management in Recent Years

This article discusses changes in the advanced prostate cancer landscape over the past decade that have induced a paradigm shift in…

Hydrogel Urothelial Cancer Therapies

Urological cancers are malignancies that affect the organs of the urinary system and male reproductive system. Of these, bladder cancer…

Loading posts...

« Previous 1 2 3 4 5 … 31 Next »